Yoshiyuki Aikawa - 06 Mar 2026 Form 4 Insider Report for SBC Medical Group Holdings Inc (SBC)

Reporting relationship: Chairman and CEO, Director, 10%+ Owner
Issuer ticker: SBC
Reported as of: 06 Mar 2026
Net transaction value: -$9,376,548
SEC form: 4
Accepted by SEC: 10 Mar 2026, 21:54:07 UTC
Prior SEC filing: 17 Sep 2024
Next SEC filing: 23 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Yuya Yoshida, Attorney-in-Fact

Key filing fact

Yoshiyuki Aikawa filed Form 4 for SBC Medical Group Holdings Inc (SBC) on 10 Mar 2026.

Key facts

This page summarizes Yoshiyuki Aikawa's Form 4 filing for SBC Medical Group Holdings Inc (SBC).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Mar 2026, 21:54.

Change

Previous filing in this sequence was filed on 17 Sep 2024.
Current net transaction value: -$9,376,548.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037003 Primary reporting owner

Aikawa Yoshiyuki

Relationship: Chairman and CEO, Director, 10%+ Owner
Address: C/O SBC MEDICAL GROUP HOLDINGS INC, 200 SPECTRUM CENTER DR., SUITE 300, IRVINE
Signature: /s/ Yuya Yoshida, Attorney-in-Fact
Signature date: 10 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBC transaction

Common Stock

Sale

Transaction value: $9,376,548
Shares: -4,422,900
Change %: -84%
Price: $2.12
Shares after: 861,600
Date: 06 Mar 2026
Ownership: By Aikawa Equity Management Co., Ltd.
Footnotes: F1, F2, F3, F4

SBC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 82,404,460
Date: 06 Mar 2026
Ownership: Direct
Footnotes: F3

SBC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,000,000
Date: 06 Mar 2026
Ownership: By GODO Kaisha Aikawa Investment
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SBC transaction Derivative

Put Options (Right to Sell)

Other

Transaction value
Shares: -44,229
Change %: -50%
Price
Shares after: 44,229
Date: 06 Mar 2026
Ownership: By Aikawa Equity Management Co., Ltd.
Underlying class: Common Stock
Underlying amount: 4,422,900
Exercise price: $2.12
Footnotes: F1, F2, F5

SBC transaction Derivative

Call Options (Right to Buy)

Other

Transaction value
Shares: +44,229
Change %
Price
Shares after: 44,229
Date: 06 Mar 2026
Ownership: By Aikawa Equity Management Co., Ltd.
Underlying class: Common Stock
Underlying amount: 4,422,900
Exercise price: $2.12
Footnotes: F1, F2, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Reflects the sale pursuant to separate share purchase agreements (the "Purchase Agreements") by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. ("AEM") to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock ("SBC shares"), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.

Footnote F2

The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.

Footnote F3

Reflects the transfer of 5,284,500 and 5,000,000 SBC shares by the Reporting Person to each of AEM and GODO Kaisha Aikawa Investment ("GODO"), respectively, each of which was a wholly owned subsidiary of the Reporting Person at the time of such transfer. As a result of the sales pursuant to the Purchase Agreements, the Reporting Person no longer controls AEM, and therefore, disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein.

Footnote F4

The 861,600 SBC shares reported as indirectly beneficially owned by the Reporting Person through AEM reflects the Reporting Person's indirect interest that he may be deemed to have shared beneficial ownership over following the transactions described herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Footnote F5

In connection with the sales described herein, pursuant to the terms of the Purchase Agreements, if the price per SBC share falls below a certain price threshold on or after April 1, 2029, the consultants described above may request the Reporting Person to redeem all shares for the same amount as the purchase price described above.

Footnote F6

In connection with the sales described herein, pursuant to the terms of the Purchase Agreements, upon satisfaction of certain conditions, the Reporting Person has the right to repurchase the AEM shares from the consultants (which were acquired as described above) for the same amount as the purchase price described above.